SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Recent news of Netflix potentially acquiring Warner Bros. is driving significant conversation around $NFLX. The community is discussing the potential impact of this deal, including concerns about market share and regulatory hurdles, while some see it as a strategic move for content dominance and long-term growth. Community members are actively speculating on the deal's likelihood and its potential effects on the streaming landscape.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending due to its strong community and meme-driven culture, with community members actively spreading awareness of the "infection". The coin, originating from $PUMP on the Solana chain, emphasizes fun and energy, attracting attention from those seeking engaging meme-based investments. The community is celebrating its organic growth and the "virus" spreading across multiple platforms, expressing confidence for the future.

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

TREASURE GLOBAL INC

TGL is trending due to a recent reverse stock split and community excitement around potential short squeeze opportunities, drawing comparisons to SMX's recent surge. Traders are closely watching for continued momentum and potential catalysts related to the company's growth initiatives. Bullish sentiment is high, with some expecting a significant run-up next week.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is trending due to positive community sentiment surrounding their ASH oral data and a subsequent upsized $100M offering, interpreted as a strong institutional buy signal.  The community is focused on the implications of the upsized offering after the data release, suggesting confidence in the company's prospects. Discussions revolve around the potential for an accelerated BLA submission and future buyout opportunities.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

TWG is trending as traders discuss its potential for a significant squeeze, drawing comparisons to recent runners like $SMX and $TGL. Community members are focused on the stock's low float and a reported FY25 profit outlook as potential catalysts. Some traders caution about risks associated with Hong Kong-based companies and potential dilutions.

MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases. The company was founded on October 30, 2014 and is headquartered in Cambridge, MA.

MetaVia Inc.

MTVA is trending due to community discussion around its low float and potential for significant price movement, with traders actively monitoring overnight action and anticipating a continued run. Some investors are optimistic about potential catalysts and the company's pipeline, while others express caution regarding dilution and the company's financials, contributing to the stock's volatile trading pattern.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

Structure Therapeutics ($GPCR) is trending as investors discuss its upcoming P2 data release and potential competition with other GLP-1 drugs. The community is focused on evaluating the data quality and management's strategic moves to shape the narrative. Some traders are also noting unusual options activity, while analysts weigh in on potential buyouts and price targets.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is trending as traders discuss the impact of weather patterns and natural gas storage levels on its price, with some anticipating a potential reversal while others remain cautious due to high production. Community members are actively trading around volatility, with differing opinions on whether recent price movements are sustainable amid winter demand and contract rollovers. Discussions also involve technical analysis and potential chart patterns.

Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.

Dyne Therapeutics Inc

Dyne Therapeutics is trending due to upcoming topline clinical results from their DELIVER trial of DYNE-251 in Duchenne Muscular Dystrophy, with a webcast planned to review the data. The community is discussing the potential impact of these results, especially in relation to existing treatments like Sarepta's. Traders are also eyeing the stock, and providing potential ROI.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending due to a positive FY2025 profit outlook, triggering an after-market surge and aggressive overnight buying, with some traders anticipating a continued run. Community discussions highlight the stock's low float and potential for a significant squeeze, drawing comparisons to other high-momentum stocks. The focus remains on overnight trading and the possibility of further gains, though some caution about high volatility and potential dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Compugen (NASDAQ:CGEN) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded Compugen from a "sell" rating to a "hold" rating in a research report on Saturday...

Analysts Set Expectations for Compugen FY2025 Earnings

Compugen Ltd. (NASDAQ:CGEN - Free Report) - Equities researchers at Leerink Partnrs increased their FY2025 earnings per share estimates for Compugen in a research report issued on Monday, November...

FY2025 EPS Estimates for Compugen Lifted by Leerink Partnrs

Compugen Ltd. (NASDAQ:CGEN - Free Report) - Investment analysts at Leerink Partnrs raised their FY2025 earnings per share estimates for shares of Compugen in a research note issued on Monday...

Compugen (NASDAQ:CGEN) Issues Quarterly Earnings Results

Compugen (NASDAQ:CGEN - Get Free Report) released its quarterly earnings results on Monday. The biotechnology company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts...

Compugen (CGEN) Reports Q3 Loss, Lags Revenue Estimates

Compugen (CGEN) delivered earnings and revenue surprises of +22.22% and -14.43%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Certara, Inc. (CERT) Q3 Earnings Surpass Estimates

Certara (CERT) delivered earnings and revenue surprises of +27.27% and -0.57%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Compugen to Participate in Stifel 2025 Healthcare Conference

Compugen to Participate in Stifel 2025 Healthcare Conference Compugen to Participate in Stifel 2025 Healthcare Conference PR Newswire HOLON, Israel, Nov. 4, 2025 HOLON, Israel, Nov. 4, 2025...

Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Top Estimates

Vertex (VRTX) delivered earnings and revenue surprises of +5.49% and +1.14%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025

Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025 Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025 PR Newswire HOLON, Israel, Oct. 27, 2025 HOLON...

Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025

Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025 Compugen to Present Pooled Analysis of COM701 in Three Phase 1...

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.

Compugen Ltd

$SOFI

$RDDT

$CVNA

$MSTR

Which stock do you think gets added to the S&amp;P 500 in today’s rebalance?

Stocktwits

Which stock do you think gets added to the S&P 500 in today’s rebalance?

Current Price	$1.51
Prev Close	$1.61
Open	$1.60
Dividend Yield	0.00%
50-Day Moving Average	$1.69
Beta	1.61
Avg. Volume	284,905.16
PE Ratio	-5.05

52-Week High	$2.66
52-Week Low	$1.13
Market Capitalization	$141.24M
EPS (Annual)	-$0.159
Price to Book	3.22
Revenue Per Employee	$376,540.54
Enterprise Value/EBITDA	N/A

CGEN
Compugen Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CGEN News

CGENCompugen Ltd